BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3205834)

  • 21. [Chemotherapy of stomach cancer].
    Gropp C; Havemann K
    Z Gastroenterol; 1982 Dec; 20(12):703-9. PubMed ID: 6819730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy improves pulmonary function in a patient with gastric cancer.
    Cunningham D; Henderson A; Soukop M
    Br J Clin Pract; 1986 Jun; 40(6):261-2. PubMed ID: 3755609
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of advanced stomach cancer].
    Starzyńska T
    Pol Tyg Lek; 1986 Nov; 41(46):1463-6. PubMed ID: 3550744
    [No Abstract]   [Full Text] [Related]  

  • 24. 5-Fluorouracil, doxorubicin and mitomycin C (FAM) combination chemotherapy for metastatic adenocarcinoma of unknown primary.
    van der Gaast A; Verweij J; Planting AS; Stoter G
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):765-8. PubMed ID: 3383976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of advanced gastric cancer which disappeared histopathologically after short-time chemotherapy].
    Hara K; Yokoyama T; Furuta K; Shinoda M; Yajima K; Yasuda S; Nakazaki S; Kiyomitsu Y; Watanabe K
    Gan No Rinsho; 1984 Apr; 30(4):399-402. PubMed ID: 6727041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Undifferentiated leukemia following treatment of gastric cancer with 5 fluorouracil, doxorubicin, mitomycin C chemotherapy.
    Gupta S; Raina V; Jain P; Gujral S; Kumar R
    J Assoc Physicians India; 2000 Jun; 48(6):639-40. PubMed ID: 11273547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemolytic uremic syndrome in a patient with gastric adenocarcinoma: partial recovery of renal function after gastrectomy.
    Ortega Marcos O; Escuin F; Miguel JL; Gómez Fernández P; Pérez Fontán M; Selgas R; Sanchez Sicilia L
    Clin Nephrol; 1985 Nov; 24(5):265-8. PubMed ID: 4075597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A combined chemotherapy with UFT and mitomycin C in advanced gastric cancer; report of 2 cases].
    Nakata K; Shigemitsu M; Joya K; Sato K; Hara S; Hanawa S
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1694-6. PubMed ID: 3927850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful outcome of treating hemolytic uremic syndrome associated with cancer chemotherapy with immunoadsorption.
    D'Souza RJ; Kwan JT; Hendry BM; Fallon M; Cunningham D
    Clin Nephrol; 1997 Jan; 47(1):58-9. PubMed ID: 9021244
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cytostatic agents in the treatment of stomach carcinoma].
    Veenhof CH; Taal BG; Neijt JP; Blijham GH
    Ned Tijdschr Geneeskd; 1987 Mar; 131(13):515-9. PubMed ID: 3574509
    [No Abstract]   [Full Text] [Related]  

  • 31. [Medical decision in clinical oncology: the example of drug therapy of gastric cancer in the advanced stage during the last decade].
    Kenis Y
    Bull Cancer; 1987; 74(2):191-5. PubMed ID: 3607302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy for advanced gastric carcinoma.
    JAMA; 1986 Jan; 255(3):321-3. PubMed ID: 3753616
    [No Abstract]   [Full Text] [Related]  

  • 33. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
    Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
    Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chemotherapy in cancers of the gallbladder and bile ducts].
    Okada S; Okazaki N
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1269-72. PubMed ID: 2069397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy of advanced gastric cancer: a study of 43 consecutive cases treated with fluorouracil, adriamycin and mitomycin C (FAM).
    Faedi M; Amadori M; Gentilini P; Ridolfi R; Ravaioli A; Amadori D; Biserni R; Bonaguri C
    Chemioterapia; 1986 Aug; 5(4):240-3. PubMed ID: 3769045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FAM therapy for advanced gastric cancer: an ideal standard?
    Cullinan SA; Moertel CG
    J Clin Oncol; 1985 Jun; 3(6):887-9. PubMed ID: 3891923
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experiences with polychemotherapy MAF (mitomycin C, adriablastine, 5-fluorouracil) in progressing metastasized prostate cancer].
    Burk K; Gropp C; de Riese W; Löbenau S
    Helv Chir Acta; 1985 Sep; 52(3-4):601-3. PubMed ID: 3934112
    [No Abstract]   [Full Text] [Related]  

  • 38. Phase-III clinical trial of adjuvant FAM2 (5-FU, adriamycin and mitomycin C) vs control in resectable gastric cancer: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group.
    Lise M; Nitti D; Buyse M; Cartei G; Fornasiero A; Guimaraes dos Santos J; Duez N
    Recent Results Cancer Res; 1988; 110():36-43. PubMed ID: 3043595
    [No Abstract]   [Full Text] [Related]  

  • 39. Cisplatin, doxorubicin, and 5-FU in combination for advanced gastric cancer.
    Vogl SE; Engstrom PF
    Cancer Treat Rep; 1984 Oct; 68(10):1273-5. PubMed ID: 6543152
    [No Abstract]   [Full Text] [Related]  

  • 40. The treatment of advanced gastric cancer.
    Wils J
    Semin Oncol; 1996 Jun; 23(3):397-406. PubMed ID: 8658224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.